Cite
HARVARD Citation
Abdulrehman, J. et al. (2021). Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals. Research and practice in thrombosis and haemostasis. 5 (5), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abdulrehman, J. et al. (2021). Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals. Research and practice in thrombosis and haemostasis. 5 (5), p. n/a. [Online].